Acute Cardiovascular Events Triggered by COVID-19-Related Stress
NCT ID: NCT04368637
Last Updated: 2020-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2020-05-03
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is a cross sectional study that will enroll patients evaluated during the COVID19 pandemic period for acute cardiovascular events.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Corticoid Therapy in Acute Myocarditis
NCT06522100
Study to Assess Cardiac Conduction of GSK1349572
NCT00996021
Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial
NCT02648464
Oral Nicorandil in ST Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
NCT04632121
A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine
NCT06113692
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The current COVID-19 pandemic has afflicted almost the whole globe. The virus can directly attack the myocyte and cause various degrees of cardiac damage and cardiovascular clinical entities. However, the stress related to the pandemic, not the direct virus-related injury, can be potentially associated with acute cardiovascular events due to a large list of physical and psycho-social stresses such as extreme physical effort, lock down, anger, fear, financial stress, sorrow, death of a significant person..etc.
This study is a cross sectional study that will enroll patients evaluated during the COVID-19 pandemic period for acute cardiovascular events not directory related to the virus infectivity, who voice certain and specific trigger(s) related to the pandemic impact on social life and physical activity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute MI (STEMI and NSTEMI).
* Sudden cardiac death
* Ventricular tachycardia
* ICD shocks.
* Stressful trigger prior to the cardiovascular event
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jordan Collaborating Cardiology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman J. Hammoudeh, MD, FACC
Interventional Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayman J Hammoudeh, MD, FACC
Role: STUDY_CHAIR
JCC Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istishari Hospital
Amman, , Jordan
Abdelhadi Hospital
Amman, , Jordan
Farah Hospital
Amman, , Jordan
Jordan Hospital
Amman, , Jordan
Specialty Hospital
Amman, , Jordan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zeina Abu Orabi, MD
Role: primary
Hadi Abu hantash, MD, FACC
Role: primary
Mahmoud Izraiq Mahmoud Izraiq, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JCCG.JoCORE.4.4040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.